Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether Venus Diagnostics Ltd. and Syngene International Limited were rightly excluded from the set of comparables for determining the arm's length price of the assessee's contract research services.
Analysis: The comparability exercise had to be undertaken on the basis of functional similarity. Venus Diagnostics Ltd. was found to be operating as a diagnostic centre and not rendering research services, making it functionally different from the assessee. Syngene International Limited was engaged in contract research as well as sale of compounds, and no segmental details were available to isolate the margin from the relevant research activity. In the absence of such segmental information and in view of the different functional profile, the exclusion of both companies from the comparable set was justified.
Conclusion: The exclusion of Venus Diagnostics Ltd. and Syngene International Limited as comparables was upheld, and the Revenue's challenge failed.
Ratio Decidendi: For transfer pricing purposes, a company cannot be treated as a comparable unless its functions are materially similar to those of the tested party and reliable segmental results are available where the company has multiple lines of business.